Genetic Technologies Ltd. (GENE)

NASDAQ: GENE · IEX Real-Time Price · USD
1.14
-0.01 (-0.87%)
Dec 5, 2022 3:15 PM EST - Market open
-0.87%
Market Cap 18.87M
Revenue (ttm) 4.72M
Net Income (ttm) -4.95M
Shares Out 9.22B
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,720
Open 1.13
Previous Close 1.15
Day's Range 1.13 - 1.15
52-Week Range 0.95 - 2.85
Beta 1.09
Analysts n/a
Price Target n/a
Earnings Date Aug 30, 2022

About GENE

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as ... [Read more]

Industry Life Sciences Tools & Services
Founded 1989
Employees 52
Stock Exchange NASDAQ
Ticker Symbol GENE
Full Company Profile

Financial Performance

In 2022, GENE's revenue was 6.79 million, an increase of 5,536.33% compared to the previous year's 120,554. Losses were -7.13 million, 0.75% more than in 2021.

Financial numbers in AUD Financial Statements

News

Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details

MELBOURNE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, welln...

1 month ago - GlobeNewsWire

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / October 13, 2022 / RedChip Companies will air a new interview with Genetic Technologies Limited (ASX:GTG)(NASDAQ:GENE) ("Company", "GTG"), a global leader in genomics-based te...

1 month ago - Accesswire

Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for br...

MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious ...

2 months ago - GlobeNewsWire

Genetic Technologies Provides Update on US Operations and Payer Engagement

MELBOURNE, Australia, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”, “GENE”), a global leader in guideline driven genomics-based tests in heal...

3 months ago - GlobeNewsWire

GENE Momentum building - a year in review

MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health, well...

3 months ago - GlobeNewsWire

Gene achieves key milestones and growth

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

4 months ago - GlobeNewsWire

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

4 months ago - GlobeNewsWire

GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

5 months ago - GlobeNewsWire

Acquisition of global direct to consumer ecommerce business

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious d...

6 months ago - GlobeNewsWire

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader in genomics-based tests in health, wellness and ...

7 months ago - GlobeNewsWire

Genetic Technologies Reports Q2 FY22 Cash Flow Results

Q2 momentum sets the stage for a strong FY22 Q2 momentum sets the stage for a strong FY22

10 months ago - GlobeNewsWire

GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

11 months ago - GlobeNewsWire

Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious ...

11 months ago - GlobeNewsWire

Genetic Technologies Reports Q1 FY22 Results

Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter Genetype MultiTest submitted for regulatory approval as comme...

1 year ago - GlobeNewsWire

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Div...

Study to focus on women of African American descent for expanded polygenic risk test Study to focus on women of African American descent for expanded polygenic risk test

1 year ago - GlobeNewsWire

BelHealth Completes Asset Sale of General Genetics Corp.

FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- September 9, 2021–BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the internation...

1 year ago - PRNewsWire

Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy

Company to present at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually September 13-15, 2021 Company to present at H.C. Wainwright 23rd Annual Global Investment Conference...

1 year ago - GlobeNewsWire

Genetic Technologies Rapidly Accelerating Commercialization Plans

MELBOURNE, Australia, July 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease, is...

1 year ago - GlobeNewsWire

Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing

Genetic Technologies Limited (NASDAQ: GENE) has agreed to acquire EasyDNA's brand and distribution rights from BelHealth for $4 million in cash and stock. EasyDNA currently sells paternity, oncology, an...

1 year ago - Benzinga

Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA

A global platform to market the Company's portfolio across 40 countries A global platform to market the Company's portfolio across 40 countries

1 year ago - GlobeNewsWire

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multipl...

MELBOURNE, Australia, July 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health business, today ...

1 year ago - GlobeNewsWire

US Patent Office Grants Foundational Pharmacogenomic Patent

MELBOURNE, Australia, June 11, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business, has be...

1 year ago - GlobeNewsWire

Infinity BiologiX, Genetic Technologies and Vault Heath launch new test to assess severity of COVID-19 in individuals

PISCATAWAY, N.J.--(BUSINESS WIRE)-- #covid19--Today, Infinity BiologiX (IBX) announces the launch of a new test meant to assess the severity of COVID-19 in individuals. The COVID-19 Risk Test is designe...

1 year ago - Business Wire

Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®

MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business, today a...

1 year ago - GlobeNewsWire

Genetic Technologies appoints Mike Tonroe as CFO

MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe to th...

1 year ago - GlobeNewsWire